Breaking News
Tuesday , October 17 2017
Home / Tag Archives: Zydus Cadila

Tag Archives: Zydus Cadila

Zydus Cadila receives final approval for Acamprosate Calcium Tablets

Zydus Cadila has received the final approval from the USFDA to market Acamprosate Calcium Delayed-Release Tablets, 333 mg. This medication is used for maintenance of abstinence from alcohol in patients with alcohol dependence. The drug will be produced at the group’s formulations manufacturing facility at Baddi. The group now has ... Read More »

Zydus receives final approval from USFDA for Budesonide Capsules

Zydus Cadila has received the final approval from the US Food & Drug Administration (USFDA) to market Budesonide Capsules, 3 mg (Enteric Coated). The drug is a corticosteroid used for its anti-inflammatory action. Budesonide Capsules will be produced at the group’s formulations manufacturing facility at the Pharma SEZ in Ahmedabad. ... Read More »